Introduction
The c-Abl protein tyrosine kinase is predominantly localized to the nucleus (Van Etten et al., 1989) . Overexpression of c-Abl causes an arrest of growth at G1 phase that is dependent on tyrosine kinase activity, nuclear localization and the SH2 domain (Mattioni et al., 1995; Sawyers et al., 1994) . c-Abl requires p53 for growth suppression, binds to p53 in vitro and enhances the transactivation function of p53 (Goga et al., 1995) . Other studies indicate that the cytotoxic function of cAbl involves both p53 and the retinoblastoma protein (pRB) (Wen et al., 1996) . c-Abl associates with pRb (Welch and Wang, 1993) and overexpression of kinaseinactive c-Abl blocks pRB-induced growth arrest (Welch and Wang, 1995) . These ®ndings and the demonstration that p34 cdc2 controls binding of c-Abl to DNA (Kipreos and Wang, 1990 Wang, , 1992 ) supported a role for c-Abl in regulation of the cell cycle.
The c-Abl kinase is activated by diverse DNA damaging agents (Kharbanda et al., 1995a,b; Liu et al., 1996b) . Exposure of cells to ionizing radiation, alkylating agents or 1-b-D-arabinofuranosylcytosine (ara-C) induces nuclear c-Abl activity (Kharbanda et al., 1995a,b; Liu et al., 1996b) . Genotoxic agents also induce binding of c-Abl to p53 (Yuan et al., 1996b) . Transient transfection of wild-type or inactivated c-Abl induces expression of the p53 eector, p21, but importantly only wild-type c-Abl induces growth arrest (Yuan et al., 1996b) . Moreover, cells expressing a dominant negative c-Abl mutant and cells null for cAbl are imparied in their ability to undergo G1 arrest in response to genotoxic stress (Yuan et al., 1996a,b) . These ®ndings have indicated that c-Abl contributes to DNA damage-induced growth arrest.
The present studies demonstrate that c-Abl is involved in the sensitivity of cells to ara-C. Ara-C misincorporates into DNA, blocks replication by terminating DNA strand elongation and induces DNA strand breaks (Kufe et al., 1980 (Kufe et al., , 1984 Ohno et al., 1988) . The results indicate that the c-Abl kinase has a pro-apoptotic function in the cellular response to ara-C.
Results and discussion
C-Abl is activated in U-937 myeloid cells treated with ara-C (Kharbanda et al., 1995b) . To assess the potential involvement of c-Abl in ara-C-induced lethality, we assayed MCF-7 epithelial cell clones that stably express the dominant negative c-Abl (K-R) (Yuan et al., 1996a,b) . MCF-7 cells expressing the empty pSR vector responded to ara-C with activation of c-Abl (Figure 1a) . By contrast, expression of c-Abl (K-R) abrogated the induction of c-Abl activity by ara-C exposure ( Figure 1a) . As assessed by clonogenic survival, MCF-7/c-Abl (K-R) cells were resistant to ara-C treatment as compared to MCF-7/pSR and wild-type MCF-7 cells (Figure 1b) . Similar results were obtained in two separately selected MCF-7/c-Abl (K-R) clones (Figure 1b ). These ®ndings suggested that activation of c-Abl contributes to ara-C-induced cell lethality.
Previous studies have demonstrated that ara-C induces apoptosis (Gunji et al., 1991) . To determine whether c-Abl regulates ara-C-induced apoptosis, we asked whether expression of c-Abl (K-R) aects the appearance of ara-C-treated cells with sub-G1 DNA content. Treatment of MCF-7/pSR cells with ara-C resulted in 28% with sub-G1 DNA (Figure 2a) . By contrast, 7% of ara-C-treated MCF-7/c-Abl (K-R) cells exhibited sub-G1 DNA. Similar results were obtained with both MCF-7/c-Abl (K-R) clones (data not shown). These ®ndings suggested that cells de®cient in c-Abl kinase exhibit resistance to ara-Cinduced apoptosis. TUNEL assays were used to con®rm the c-Abl-dependent eects. Exposure of MCF-7/pSR cells to ara-C was associated with increased TUNEL staining as compared to ara-Ctreated MCF-7/c-Abl (K-R) cells (Figure 2b ). Taken together with studies on ara-C-induced killing, these results indicate that c-Abl kinase contributes to ara-Cinduced apoptosis.
Whereas c-Abl binds to p53 (Yuan et al., 1996b) and p53 regulates induction of apoptosis by DNA-damaging agents (Lee and Bernstein, 1993; Lowe et al., 1993a) , we asked whether the eects of c-Abl (K-R) on ara-Cinduced apoptosis are dependent on p53. MCF-7/E6 cells that stably express the human papillomavirus E6 protein to promote p53 degradation (Schener et al., 1990) were treated with ara-C. Ara-C-induced increases in p53 were attenuated in the MCF-7/E6 cells as compared to that in MCF-7/pSR and MCF-7/c-Abl (K-R) cells (Figure 3a) . Moreover, induction of p21, an eector of p53, was blocked in ara-C-treated MCF-7/E6 cells ( Figure 3a) . The lethal eects of ara-C were decreased in the MCF-7/E6 cells as compared to MCF-7/pSR cells ( Figure 3b ). Stable expression of both E6 and c-Abl (K-R) resulted in even more resistance to ara-Cinduced killing (Figure 3b ). Stable expression of c-Abl (K-R) in p53 7/7 MEFs also conferred partial abrogation of ara-C-induced apoptosis as compared to control p53 7/ 7 cells (Figure 3c ). These ®ndings indicate that c-Abl can regulate ara-C-induced apoptosis at least in part by a p53-independent mechanism.
To provide additional support for involvement of cAbl in ara-C-induced lethality, we compared MEFs de®cient in c-Abl (abl 7/7 ) (Tybulewicz et al., 1991) and after stable expression of c-Abl or c-Abl (K-R) in this background. Ara-C treatment had no eect on c-Abl expression in the Abl + or Abl (K-R) + transfectants (Figure 4a ). There was also no detectable c-Abl activity in the Abl 7/7 and Abl (K-R) + cells (data not shown), while ara-C activated c-Abl in the Abl + cells (Kharbanda et al., 1995b) . As determined by clonogenic survival, sensitivity to ara-C was similar in the Abl 7/7 and Abl (K-R) + cells ( Figure 4b ). Importantly, the Abl 7/7 and Abl (K-R) + cells were more resistant to ara-C as compared to the Abl + cells (Figure 4b ). These ®ndings indicated that expression of kinase-active c-Abl is associated with increased sensitivity to ara-C-induced killing.
The eects of ara-C on apoptosis of the MEFs were assessed by sub-G1 DNA content and TUNEL staining. Treatment of the Abl 7/7 MEFs with ara-C resulted in 11% with sub-G1 DNA (Figure 5a ). By contrast, the Abl + cells were more sensitive to ara-Cinduced apoptosis with 22% positive for sub-G1 DNA (Figure 5a ). The ®nding that only 10% of the Abl (K-R) + cells exhibit sub-G1 DNA after exposure to ara-C supported involvement of kinase-active c-Abl in this response (Figure 5a) . Exposure of the Abl 7/7 and Abl (K-R) + cells to ara-C also resulted in less TUNEL staining as compared to that obtained for the Abl + cells (Figure 5b and data not shown).
The present results support a role for the c-Abl kinase in sensitivity of cells to ara-C-induced killing. Ara-C incorporates into elongating DNA strands and thereby functions as a relative chain terminator during S phase (Kufe et al., 1980 (Kufe et al., , 1984 Ohno et al., 1988) . Nuclear cAbl is activated during S phase by genotoxic stress (Kharbanda et al., 1995a,b; Liu et al., 1996b) . Recent studies suggest that activation of the DNA-dependent protein kinase (DNA-PK), and perhaps the ATM gene product, by DNA damage contributes to induction of cAbl activity Shafman et al., 1997; Baskaran et al., 1997) . Other studies have shown that overexpression of the dominant negative, kinase inactive c-Abl (K-R) in MCF-7 cells blocks induction of c-Abl kinase activity by ionizing radiation (Yuan et al., 1996a,b) . Similar results were obtained in the ara-Ctreated MCF-7/c-Abl (K-R) cells. These ®ndings and the demonstration that cells de®cient in c-Abl exhibit resistance to an S phase selective agent suggest that cAbl activation contributes to lethality induced by certain types of DNA damage.
The present studies also demonstrate that overexpression of c-Abl (K-R) in MCF-7 cells blocks induction of apoptosis. A pro-apoptotic role for kinase-active c-Abl was also demonstrated in Abl agents (Bedi et al., 1995) . Whereas the basis for an anti-apoptotic eect of Bcr-Abl is unclear, Bcr-Abl could interefere with a pro-apoptotic function of c-Abl. In this context, alterations of the p53 protein confer resistance to induction of apoptosis by genotoxic agents (Lee and Bernstein, 1993; Lowe et al., 1993b) . c-Abl associates with p53 in the response of MCF-7 cells to DNA damage and contributes to the arrest of cells in G1 phase by a p53-dependent mechanism (Yuan et al., 1996b) . However, studies in MCF-7/E6 cells suggest that involvement of c-Abl in apoptosis can occur at least in part independently of p53. A c-Abldependent and p53-independent mechanism was con®rmed in p53
cells induced to undergo apoptosis by treatment with ara-C. c-Abl is involved in ara-C-induced activation of JNK/SAPK and p38 MAPK (Pandey et al., 1996) , and these stress-activated kinases have been implicated in apoptosis (Johnson et al., 1996; Verheij et al., 1996; Xia et al., 1995) . More recent studies have demonstrated that NF-kB signaling regulates induction of apoptosis (Beg and Baltimore, 1996; Liu et al., 1996a; Van Antwerp et al., 1996; Wang et al., 1996) . However, there is no known association between c-Abl signaling and the NF-kB pathway.
Materials and methods
Cell culture and colony assays MCF-7 cells and mouse embryo ®broblasts (MEFs) were grown as described (Yuan et al., 1996a) . Null pSRaMSVtKneo, pSRaMSVc-AblK (290) and 10 4 cells/60 mm dish 12 h before drug treatment. Cells were incubated with ara-C for 1 h, washed and refed with fresh medium. Colony formation was assessed at 10 days after drug treatment. Colonies containing more than 50 cells were scored as positive.
c-Abl kinase assays
Proteins were prepared and subjected to immunoprecipitation with anti-c-Abl (Ab-3; Oncogene Science) as described (Kharbanda et al., 1995a) . Immune complex kinase assays were performed by incubating the immunoprecipitates in kinase buer (50 mM Tris, pH 7.5, 10 mM MgCl 2 , 10 mM MnCl 2 , 1 mM DTT) with 5 mg GST-Crk (120 ± 225) and 5 mCi [g-32 P]ATP for 30 min at 308C. Phosphorylation was analysed by 10% SDS ± PAGE and autoradiography.
Apoptosis assays
DNA content was assessed by staining ethanol-®xed cells with propidium iodide and monitoring by FACScan. Cells with sub-G1 DNA content were determined with a Mod®t LT program (Verity Software, Inc.). TUNEL assays were performed with ApopTag Fluorescein (Oncor, Gaithersburg, MD).
Immunoblot analysis
Cells were lysed in 1% NP-40 lysis buer. Proteins were resolved by SDS ± PAGE, transferred to nitrocellulose ®lters and analysed with anti-p53 (Ab-1, Oncogene Science), anti-p21 (SC-397, Santa Cruz Biotechnology, San Diego, CA), anti-c-Abl (Ab-3) or anti-PCNA (PC10; Santa Cruz). Proteins were detected with an ECL (Amersham, Arlington Heights, IL) system.
Abbreviations
The abbreviations used are: ara-C, 1-b-D-arabinofuranosylcytosine; pRB, retinoblastoma protein. 
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